Therapeutic Potential of DNAzyme Loaded on Chitosan/Cyclodextrin Nanoparticle to Recovery of Chemosensitivity in the MCF-7 Cell Line
- 122 Downloads
Commonly, acquired resistances to anticancer drug are mediated by overexpression of a membrane-associated protein that encode via multi-drug resistance gene-1 (MDR1). Herein, the mRNA-cleaving DNAzyme that targets the mRNA of MDR1 gene in doxorubicin-resistant breast cancer cell line (MCF-7/DR) loaded on the chitosan β-cyclodextrin complexes was used as a tropical agent. Chitosan/β-cyclodextrin complexes were used to deliver DNAzymes into cancer cells. Determination of the physicochemical characteristics of the particles was done by photon correlation spectroscopy and scanning electron microscopy. The encapsulation efficiency of the complexes was tested by using gel retardation assay. Positively charged nanoparticles interacted with DNAzyme that could perform as an efficient DNAzyme transfection system. The rationale usage of this platform is to sensitize MCF-7/DR to doxorubicin by downregulating the drug-resistance gene MDR1. Results demonstrated a downregulation of MDR1 mRNAs in MCF-7/DR/DNZ by real-time PCR, compared to the MCF-7/DR as control. WST1 assay showed the 22-fold decrease in drug resistance on treated cells 24 h after transfection. Results showed the intracellular accumulation of Rh123 increased in the treated cells with DNAzyme. Results suggested a potential platform in association with chemotherapy drug for cancer therapy and indicated extremely efficient at delivery of DNAzyme in restoring chemosensitivity.
KeywordsMulti-drug resistance DNAzyme β-Cyclodextrin Chitosan Chemosensitization
This study received a financial support from the Research Council of the Shahid Bahonar University of Kerman (Iran).
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflicts of interest.
- 4.Motomura, S., Motoji, T., Takanashi, M., Wang, Y. H., Shiozaki, H., Sugawara, I., et al. (1998). Inhibition of P-glycoprotein and recovery of drug sensitivity of human acute leukemic blast cells by multidrug resistance gene (mdr1) antisense oligonucleotides. Blood, 91(9), 3163–3171.Google Scholar
- 5.Gao P, Zhou G, Zhang Q, Li H, Mu K, Yuan Y, et al. (2006). Reversal MDR in breast carcinoma cells by transfection of ribozyme designed according the secondary structure of mdr1 mRNA. The Chinese Journal of Physiology, 49(2):96.Google Scholar
- 24.Alexakis T, Boadi DK, Quong D, Groboillot A, O’neill I, Poncelet D, et al. (1995). Microencapsulation of DNA within alginate microspheres and crosslinked chitosan membranes for in vivo application. Biotechnology and Applied Biochemistry 50(1):93–106.Google Scholar
- 26.Csaba, N., Köping-Höggård, M., Fernandez-Megia, E., Novoa-Carballal, R., Riguera, R., & Alonso, M. J. (2009). Ionically crosslinked chitosan nanoparticles as gene delivery systems: effect of PEGylation degree on in vitro and in vivo gene transfer. Journal of Biomedical Nanotechnology, 5(2), 162–171.CrossRefGoogle Scholar
- 31.Trapani, A., Lopedota, A., Franco, M., Cioffi, N., Ieva, E., Garcia-Fuentes, M., et al. (2010). A comparative study of chitosan and chitosan/cyclodextrin nanoparticles as potential carriers for the oral delivery of small peptides. European Journal of Pharmaceutics and Biopharmaceutics, 75(1), 26–32.CrossRefGoogle Scholar
- 43.Ramachandran, C., & Wellham, L. L. (2003). Effect of MDR1 phosphorothioate antisense oligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts. Anticancer Research, 23(3B), 2681–2690.Google Scholar
- 45.Beale, G., Hollins, A. J., Benboubetra, M., Sohail, M., Fox, S. P., Benter, I., et al. (2003). Gene silencing nucleic acids designed by scanning arrays: anti-EGFR activity of siRNA, ribozyme and DNA enzymes targeting a single hybridization-accessible region using the same delivery system. Journal of Drug Targeting, 11(7), 449–456.CrossRefGoogle Scholar
- 52.Takechi-Haraya, Y., Tanaka, K., Tsuji, K., Asami, Y., Izawa, H., Shigenaga, A., et al. (2015). Molecular complex composed of β-cyclodextrin-grafted chitosan and pH-sensitive amphipathic peptide for enhancing cellular cholesterol efflux under acidic pH. Bioconjugate Chemistry, 26(3), 572–581.CrossRefGoogle Scholar